Piperlongumine Induces Apoptosis in Colorectal Cancer HCT 116 Cells Independent of Bax, p21 and p53 Status

Colorectal cancer is a common type of cancer with reported resistance to treatment, in most cases due to loss of function of apoptotic and cell-cycle proteins. Piperlongumine (PPLGM) is a natural alkaloid isolated from Piper species, with promising anti-cancer properties. This study investigated whe...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research Vol. 38; no. 11; pp. 6231 - 6236
Main Authors: DA Silva Machado, Fernanda, Munari, Fernanda Mosena, Scariot, Fernando Joel, Echeverrigaray, Sergio, Aguzzoli, Cesar, Pich, Claus Tröger, Kato, Massuo Jorge, Yamaguchi, Lydia, Moura, Sidnei, Henriques, João Antonio Pêgas, Roesch-Ely, Mariana
Format: Journal Article
Language:English
Published: Greece International Institute of Anticancer Research 01-11-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Colorectal cancer is a common type of cancer with reported resistance to treatment, in most cases due to loss of function of apoptotic and cell-cycle proteins. Piperlongumine (PPLGM) is a natural alkaloid isolated from Piper species, with promising anti-cancer properties. This study investigated whether PPLGM is able to induce cell death in colorectal carcinoma HCT 116 cells expressing wild-type or deficient in Bax, p21 or p53. PPLGM was extracted from roots of Piper tuberculatum. Cell viability was determined by reduction of 3-(4,5-dimethilthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and clonogenic assay. Cell death was evaluated by acridine orange/ethidium bromide staining and flow cytometry. Plasmid cleavage activity and circular dichroism DNA interaction were also analyzed. PPLGM induced selective cell death in all cell lines (IC range from 10.7 to 13.9 μM) with an increase in the number of late apoptotic cells and different profiles in cell-cycle distribution. Plasmid DNA analysis showed that PPLGM does not interact directly with DNA. This paper suggests that PPLGM may be a promising candidate in colorectal cancer therapy.
ISSN:0250-7005
1791-7530
DOI:10.21873/anticanres.12978